ZHANG Keming
Hepatobiliary Surgery
Chief Doctor
Hepatobiliary Surgery
Associate Professor, Chief Doctor
General Specialist Clinic: Monday morning, Wednesday all day. International Medical Specialist Clinic: Tuesday morning.
Especially skilled in radical resection and minimally invasive surgical treatment for biliary malignancies including gallbladder cancer and cholangiocarcinoma, and published two related SCI papers; Especially skilled in precise anatomical minimally invasive liver resection for primary liver cancer, minimally invasive surgical comprehensive treatment for metastatic liver cancer; minimally invasive surgical treatment for benign and malignant pancreatic tumors including pancreatic cancer, IPMN, solid pseudopapillary tumor, etc.; minimally invasive surgical treatment for splenic tumors. Especially skilled in minimally invasive treatment for gallstones and bile duct stones, with rich surgical experience.
Assistant Advisor to Doctoral Students at Peking University Health Science Center;
Review Expert for the National Natural Science Foundation of China;
Member of the Biliary Tract Tumors Professional Committee of the Chinese Society of Clinical Oncology (CSCO);
Member of the International Hepato-Pancreato-Biliary Association (IHPBA);
Member of the Hepatology (Integrated Traditional Chinese and Western Medicine) Professional Committee of the Chinese Society of Research-Oriented Hospitals;
Member, Hepatobiliary and Pancreatic Tumors Specialized Committee, China Association of Geriatric Health Care;
Young Member, Shock and Sepsis Committee, Chinese Society of Research-oriented Hospitals;
Director, Hepatology Specialists Branch, Beijing Medical Association;
Member, Hepatobiliary and Pancreatic Surgery Specialized Committee, Cross-Strait Medical and Health Exchange Association;
Member and Deputy Secretary-General, Hepatobiliary and Pancreatic Tumors Expert Committee, Beijing Health Promotion Association;
Member of the Expert Review Panel for Science and Technology Projects of the Beijing Municipal Science and Technology Commission and the Zhongguancun Science Park Management Committee;
Member of the Editorial Board of Oncology and Translational Medicine and Executive Editor of New Perspectives in Medicine, among others.
In 2003, he was recommended without an entrance exam by the Clinical Medicine (English-Track) program at China Medical University to pursue a master’s degree at the Eastern Hepatobiliary Surgery Hospital of the Second Military Medical University of the People’s Liberation Army, where he systematically studied standardized surgical treatment for primary liver cancer and in situ liver transplantation techniques;
In 2005, he qualified for direct admission to a doctoral program and began his doctoral studies;
In 2008, after earning his Ph.D., he was assigned to work in the Department of Hepatobiliary Surgery at the PLA Organ Transplant Center;
In 2014, I conducted postdoctoral research at the Clinical Postdoctoral Research Station of the PLA General Hospital (301 Hospital), conducting in-depth research on immune dysfunction following severe trauma and infection, as well as its underlying regulatory mechanisms. I received one Category I grant from the China Postdoctoral Science Foundation General Program and one grant from the National Natural Science Foundation of China General Program; my research results led to one national invention patent;
In 2019, he visited the National Center for Global Health and Medicine (NCGM) in Japan and the University of Tokyo School of Medicine to systematically study anatomical precision liver resection techniques and conduct a comparative analysis of differences in the diagnosis and treatment of primary liver cancer between China and Japan.
Major Research Achievements:
Principal investigator of one General Program grant from the National Natural Science Foundation of China;
Principal investigator of one Category I General Program grant from the China Postdoctoral Science Foundation;
Led one clinical research project on translational therapy for early- to late-stage primary liver cancer;
Led two research projects on immune-related mechanisms in gallbladder cancer;
Published more than 10 SCI-indexed papers as first or corresponding author, and 10 papers in domestic core journals;
Obtained one national invention patent;
Contributed to two Chinese monographs and one English monograph.
At the 11th Annual Medical Scientists Conference (2026), recognized as a driving force advancing the industry and awarded the honor of “Top Ten Rising Stars in Medicine”
Third Prize in the Open Liver Resection category of the Surgical Video Competition on Precision Hepatic Parenchymal Disconnection Techniques, hosted by the Chinese Journal of Hepatobiliary Surgery
Second Prize in the First Tiantan Elite Night—National Young Physicians Surgical Competition, hosted by Tiantan Hospital
Outstanding Physician at Peking University International Hospital
Outstanding Individual in Scientific Research at Peking University International Hospital